Patients with worse lung function, a greater extent of fibrosis on HRCT, or a UIP pattern on HRCT are at higher risk of progression of their ILD. However, predicting the onset of PPF remains ...

Biopsies taken from patients with fibrosing alveolitis appear similar to those seen in usual interstitial pneumonia (UIP ... and some degree of pulmonary fibrosis is found in the majority ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...

TCGFB, a private biotech founded by healthcare VC The Column Group, is tapping California biotech Surrozen to discover ...

in the context of idiopathic pulmonary fibrosis (IPF). Design, Setting, and Patients: Retrospective review of the effects of ACEI and statins on survival of 478 patients with IPF seen at Mayo ...

chronic obstructive pulmonary disease, cystic fibrosis, asthma, interstitial lung disease, bronchiectasis, benign and malignant neoplasms, and lung transplantation. The Lung Institute has developed a ...

The effort by the Center for Regenerative Medicine of Boston University, Boston Medical Center, and GSK aims to find new ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

Sep. 27, 2023 — Lung fibrosis is a debilitating disease affecting nearly 250,000 people in the U.S. alone with 50,000 new cases reported each year. There is currently no cure and limited ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...